Pulmonary surfactant homeostasis and altered macrophage function

Lung Macrophages in Health and Disease

Volumn , Issue , 2009, Pages 1-13

  Glasser, S W ^a   Senft, A P ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884436091     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805020810901010001     Document Type: Chapter

References (83)

1. Martin TR, Frevert CW. Innate immunity in the lungs. Proc Am Thorac Soc 2005; 2(5):403-11.
2. Suzuki T, Chow CW, Downey GP. Role of innate immune cells and their products in lung immunopathology. Int J Biochem Cell Biol 2008;40(6-7):1348-61.
3. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8(12):958-69.
4. Randell SH, Boucher RC; University of North Carolina Virtual Lung Group. Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol 2006; 35(1):20-8.
5. Bartlett JA, Fischer AJ, McCray PB Jr. Innate immune functions of the airway epithelium. Contrib Microbiol 2008; 15:147-63.
6. Moya F, Maturana A. Animal-derived surfactants versus past and current synthetic surfactants: current status. Clin Perinatol 2007; 34(1):145-77.
7. Ikegami M. Surfactant catabolism. Respirology 2006; 11 Suppl:S24-7.
8. Forbes A, Pickell M, Foroughian M, et al. Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats. J Appl Physiol 2007; 103(2):637-45.
9. Kramer BW, Jobe AH, Ikegami M. Exogenous surfactant changes the phenotype of alveolar macrophages in mice. Am J Physiol Lung Cell Mol Physiol 2001; 280(4):L689-94.
10. Wang L, Scabilloni JF, Antonini JM, et al. Role of lung surfactant in phagocytic clearance of apoptotic cells by macrophages in rats. Lab Invest 2006; 86(5):458-66.
11. Kingma PS, Whitsett JA. In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol 2006; 6(3):277-83.
12. Haagsman HP, Hogenkamp A, van Eijk M, et al. Surfactant collectins and innate immunity. Neonatology 2008; 93(4):288-94.
13. Korfhagen TR. Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis. Am J Respir Cell Mol Biol 2001; 25(6):668-714.
14. LeVine AM, Hartshorn K, Elliott J, et al. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 2002; 282(3):L563-72.
15. Harrod KS, Trapnell BC, Otake K, et al. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol 1999; 277(3 Pt 1):L580-8.
16. LeVine AM, Gwozdz J, Stark J, et al. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999; 103(7):1015-21.
17. LeVine AM, Kurak KE, Bruno MD, et al. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998; 9(4):700-8.
18. LeVine AM, Bruno MD, Huelsman KM, et al. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol. 1997; 158(9):4336-40.
19. Gaynor CD, McCormack FX, Voelker DR, et al. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995; 155(11):5343-51.
20. Beharka AA, Gaynor CD, Kang BK, et al. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002; 169(7):3565-73.
21. Beharka AA, Crowther JE, McCormack FX, et al. Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity. J Immunol 2005; 175(4):2227-36.
22. Kuronuma K, Sano H, Kato K, et al. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J Biol Chem 2004; 279(20):21421-30.
23. Lin PM, Wright JR. Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes. Am J Physiol Lung Cell Mol Physiol 2006; 291(6):L1199-206.
24. Watford WT, Smithers MB, Frank MM, et al. Surfactant protein A enhances the phagocytosis of C1q-coated particles by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002; 283(5):L1011-22.
25. Sano H, Sohma H, Muta T, et al. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol 1999; 163(1):387-95.
26. Borron P, McIntosh JC, Korfhagen TR, et al. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 2000; 278(4):L840-7.
27. Murakami S, Iwaki D, Mitsuzawa H, et al. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J Biol Chem 2002; 277(9):6830-7.
28. Sato M, Sano H, Iwaki D, et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NFkappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J Immunol 2003; 171(1):417-25.
29. Yamada C, Sano H, Shimizu T, et al. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization. J Biol Chem 2006; 281(31):21771-80.
30. Korfhagen TR, Sheftelyevich V, Burhans MS, et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998; 273(43):28438-43.
31. Botas C, Poulain F, Akiyama J, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A 1998; 95(20):11869-74.
32. Yoshida M, Korfhagen TR, Whitsett JA. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 2001; 166(12):7514-9.
33. Hawgood S, Ochs M, Jung A, et al. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol Lung Cell Mol Physiol 2002; 283(5):L1002-10.
34. Ikegami M, Na CL, Korfhagen TR, et al. Surfactant protein D influences surfactant ultrastructure and uptake by alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 2005; 288(3):L552-61.
35. Zhang L, Ikegami M, Dey CR, et al. Reversibility of pulmonary abnormalities by conditional replacement of surfactant protein D (SP-D) in vivo. J Biol Chem 2002; 277(41):38709-13.
36. LeVine AM, Whitsett JA, Gwozdz JA, et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165(7):3934-40.
37. Senft AP, Korfhagen TR, Whitsett JA, et al. Surfactant protein D regulates the cell surface expression of alveolar macrophage beta(2)-integrins. Am J Physiol Lung Cell Mol Physiol 2007; 292(2):L469-75.
38. Senft AP, Korfhagen TR, Whitsett JA, et al. Surfactant protein-D regulates soluble CD14 through matrix metalloproteinase-12. J Immunol. 2005; 174(8):4953-9.
39. Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 2001; 63:555-78.
40. Augusto L, Le Blay K, Auger G, et al. Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am J Physiol Lung Cell Mol Physiol 2001; 281(4):L776-85.
41. Augusto LA, Synguelakis M, Espinassous Q, et al. Cellular antiendotoxin activities of lung surfactant protein C in lipid vesicles. Am J Respir Crit Care Med 2003; 168(3):335-41.
42. Nogee LM, Dunbar AE 3rd, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344(8):573-9.
43. Amin RS, Wert SE, Baughman RP, et al. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr 2001; 139(1):85-92.
44. Glasser SW, Detmer EA, Ikegami M, et al. Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem 2003; 278(16):14291-8.
45. Glasser SW, Burhans MS, Korfhagen TR, et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci U S A 2001; 98(11):6366-71.
46. Glasser SW, Senft AP, Whitsett JA, et al. Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice. J Immunol 2008; 181(1):621-8.
47. Mora AL, Torres-González E, Rojas M, et al. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol 2006; 35(4):466-73.
48. Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001; 42(7):1007-17.
49. Huuskonen J, Abedin M, Vishnu M, et al. Dynamic regulation of alternative ATP-binding cassette transporter A1 transcripts. Biochem Biophys Res Commun 2003; 306(2):463-8.
50. McNeish J, Aiello RJ, Guyot D, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci U S A 2000; 97(8):4245-50.
51. Bates SR, Tao JQ, Collins HL, et al. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289(6):L980-9.
52. Bortnick AE, Favari E, Tao JQ, et al. Identification and characterization of rodent ABCA1 in isolated type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 2003; 285(4):L869-78.
53. Yamano G, Funahashi H, Kawanami O, et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett 2001; 508(2):221-5.
54. Mulugeta S, Gray JM, Notarfrancesco KL, et al. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002; 277(25):22147-55.
55. Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004; 350(13):1296-303.
56. Bullard JE, Wert SE, Whitsett JA, et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005; 172(8):1026-31.
57. Cheong N, Zhang H, Madesh M, et al. ABCA3 is critical for lamellar body biogenesis in vivo. J Biol Chem 2007; 282(33):23811-7.
58. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 2007; 62(2):176-9.
59. Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005; 1(2):121-31.
60. Baldán A, Tarr P, Vales CS, et al. Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis. J Biol Chem 2006; 281(39):29401-10.
61. Baldán A, Gomes AV, Ping P, et al. Loss of ABCG1 results in chronic pulmonary inflammation. J Immunol 2008; 180(5):3560-8.
62. Wojcik AJ, Skaflen MD, Srinivasan S, et al. A critical role for ABCG1 in macrophage inflammation and lung homeostasis. J Immunol 2008; 180(6):4273-82.
63. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349(26):2527-39.
64. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A 1994; 91(12):5592-6.
65. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264(5159):713-6.
66. Yoshida M, Ikegami M, Reed JA, et al. GM-CSF regulates protein and lipid catabolism by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2001; 280(3):L379-86.
67. Ballinger MN, Paine R 3rd, Serezani CH, et al. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 2006; 34(6):766-74.
68. Shibata Y, Berclaz PY, Chroneos ZC, et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001; 15(4):557-67.
69. Berclaz PY, Shibata Y, Whitsett JA, et al. GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma Rmediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung. Blood 2002; 100(12):4193-200.
70. Bonfield TL, Russell D, Burgess S, et al. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002; 27(4):481-6.
71. Uchida K, Nakata K, Trapnell BC, et al. High-affinity autoantibodies specifically eliminate granulocytemacrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004; 103(3):1089-98.
72. Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005; 171(10):1142-9.
73. Thomassen MJ, Barna BP, Malur AG, et al. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J Lipid Res 2007; 48(12):2762-8.
74. Suzuki T, Sakagami T, Rubin BK, et al. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med 2008; 205(12):2703-10.
75. Robb L, Drinkwater CC, Metcalf D, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A 1995; 92(21):9565-9.
76. Sheppard, D. Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev 2003; 83(3):673-86.
77. Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96(3):319-28.
78. Koth LL, Alex B, Hawgood S, et al. Integrin beta6 mediates phospholipid and collectin homeostasis by activation of latent TGF-beta1. Am J Respir Cell Mol Biol 2007; 37(6):651-9.
79. Curfs DM, Ghesquiere SA, Vergouwe MN, et al. Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J Biol Chem 2008; 283(31):21640-8.
80. Abe A, Hiraoka M, Wild S, et al. Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J Biol Chem 2004; 279(41):42605-11.
81. Hiraoka M, Abe A, Lu Y, et al. Lysosomal phospholipase A2 and phospholipidosis. Mol Cell Biol 2006; 26(16):6139-48.
82. Lian X, Yan C, Yang L, et al. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. Am J Physiol Lung Cell Mol Physiol 2004; 286(4):L801-7.
83. Lian X, Yan C, Qin Y, et al. Macrophage-specific expression of human lysosomal acid lipase corrects inflammation and pathogenic phenotypes in lal-/- mice. Am J Pathol 2006; 169(3):916-26.